Tandem announces FDA approval of their new Mobi insulin pump.
Tandem has announced FDA approval of their new Mobi insulin pump. The new system has similar features to Tandem’s T:Slim pump, including Control IQ (automated insulin delivery) technology.
However, there are several important differences:
The differences between the Tandem T:Slim and Mobi insulin pumps.
- Mobi is about half the size of the T:Slim
- The cartridge holds up to 200 units of insulin
- The pump has only one button (for delivering boluses in fixed increments). All other programming is performed via an iPhone mobile app
- Any Tandem infusion set can be used, but there is also a 5” tubing option
- The pump can placed in a sleeve for adhering directly to the skin (a clip option is also available)
- It can be charged wirelessly
Mobi is approved for ages 6 and up. Those who purchase a Tandem T:Slim pump between now and the end of 2023 can upgrade to Mobi for $199 once it becomes available. Those using other pumps (including current T:Slim users) can switch to Mobi for $999 as long as there is sufficient time remaining on the current pump’s warranty.
For more information, visit https://www.tandemdiabetes.com/products/tandem-mobi or call 877-801-6901.
Leave A Comment